MediPharm Labs (TSE:LABS) Sets New 12-Month Low – What’s Next?

Shares of MediPharm Labs Corp. (TSE:LABS) reached a new 52-week low on Tuesday . The company traded as low as C$0.06 and last traded at C$0.07, with a volume of 214232 shares traded. The stock had previously closed at C$0.07.

MediPharm Labs Stock Performance

The firm has a market capitalization of C$27.35 million, a P/E ratio of -2.17 and a beta of -0.38. The company has a debt-to-equity ratio of 1.12, a current ratio of 3.20 and a quick ratio of 3.10. The firm has a 50-day moving average price of C$0.07 and a two-hundred day moving average price of C$0.07.

MediPharm Labs Company Profile

Founded in 2015, MediPharm Labs specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API), and advanced derivative products produced in a GMP-certified facility with ISO-standard clean rooms. MediPharm has invested in an expert research-driven team, state-of-the-art technology, advanced purification methodologies, and purpose-built facilities to deliver pure, trusted, precision-dosed cannabinoid products for domestic and international markets.